OraSure Technologies, Inc. (OSUR)

Market Cap	271.52M
Revenue (ttm)	224.26M
Net Income (ttm)	11.37M
Shares Out	74.59M
EPS (ttm)	0.15
PE Ratio	24.10
Forward PE	61.69
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,094,677
Open	3.700
Previous Close	3.790
Day's Range	3.605 - 3.830
52-Week Range	3.605 - 8.450
Beta	0.04
Analysts	Hold
Price Target	5.50 (+51.1%)
Earnings Date	Nov 6, 2024

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection d...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Nov 12, 1986
• Employees: 638
• Stock Exchange: NASDAQ
• Ticker Symbol: OSUR
• Website: https://www.orasure.com

Analyst Forecast

According to 2 analysts, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 51.10% from the latest price.

Price Target

$5.5

(51.10% upside)

Analyst Consensus: Hold